Glycoxidation and inflammation in chronic haemodialysis patients.
BACKGROUND
Uraemia and haemodialysis treatment are associated with microinflammation and oxidative as well as carbonyl stress, which result in enhanced formation of glycoxidation products. Although both glycoxidation and inflammation can contribute to severe vascular and cardiovascular complications, the role that these pathogenic mechanisms play in the complex response of the whole organism remains to be elucidated.


METHODS
We performed a cross-sectional study in 34 clinically stable chronic haemodialysis patients and in 14 healthy controls while determining serum concentrations of pentosidine, fluorescent advanced glycation end-products (AGEs), advanced oxidation protein products (AOPPs) and acute phase reactants. We further assessed the relationship between these glycoxidation products and parameters of inflammation.


RESULTS
Glycoxidation products as well as certain acute phase reactants were elevated in haemodialysis patients. There were significant correlations between AOPPs and inflammatory parameters such as orosomucoid (0.39, P < 0.05), fibrinogen (0.49, P < 0.05) and pregnancy-associated protein A (PAPP-A; 0.46, P < 0.05), but no correlations between pentosidine or fluorescent AGEs and any of the inflammatory parameters.


CONCLUSIONS
Oxidative damage showed a closer relationship to inflammation than advanced glycation (glycoxidation). AOPPs may represent a superior acute biochemical marker, whereas AGEs may better describe chronic long-lasting damage.
Kalousová
Marta
M
Institute of Medical Biochemistry, Department of Medicine Strahov, First Faculty of Medicine, Charles University and General University Hospital, Katerinská 32, CZ 121 08 Prague 2, Czech Republic.
Sulková
Sylvie
S
Fialová
Lenka
L
Soukupová
Jirina
J
Malbohan
Ivan Matous
IM
Spacek
Pavel
P
Braun
Martin
M
Mikulíková
Ludmila
L
Fortová
Magdaléna
M
Horejsí
Magdaléna
M
Tesar
Vladimír
V
Zima
Tomás
T
D000209:Acute-Phase Proteins / Q000276:immunology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D003430:Cross-Sectional Studies; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood / Q000276:immunology*; D006031:Glycosylation; D006801:Humans; D007154:Immune System Diseases / Q000276:immunology* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000276:immunology / Q000502:physiology*; D006435:Renal Dialysis / Q000009:adverse effects*
D000209:Acute-Phase Proteins; D015415:Biomarkers; D017127:Glycation End Products, Advanced